Member Exclusive NEWS ROUND-UP

Cell therapy weekly: First FDA-monitored clinical trial for the use of stem cells in hypoplastic left heart syndrome patients

This week: Japanese pharma company offers AUS$202 million for Cynata Therapeutics (Australia) and US$3 million grant for research into mesenchymal stem cell-based Alzheimer's therapy.

Go to the profile of RegMedNet
Jul 25, 2019

Please sign in or register for FREE

No comments yet.